Trial · NCT00604214
Outcomes13
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | 28-Day All-Cause Mortality | Day 28 | All randomized participants with known mortality status at Day 28. | percentage of participants | NUMBER |
| SECONDARY | 28-Day All-Cause Mortality in Participants With Severe Protein C Deficiency | Day 28 | All randomized participants with severe protein C deficiency at Baseline with known mortality status at Day 28. | percentage of participants | NUMBER |
| SECONDARY | Average Cardiovascular Sequential Organ Failure Assessment (SOFA) Score Day 1 Through Day 28 | Day 1 through Day 28 | All randomized participants with any post-baseline data on Day 1 through Day 28. For those days when a participant is alive, but no data are available, last observation carried forward (LOFC) is used to impute the missing data. A non-surviving participant receives a score of 4 (worst score) for the day of death and every day thereafter. | units on a scale | MEAN |
| SECONDARY | Average Respiratory Sequential Organ Failure Assessment (SOFA) Score Day 1 Through Day 28 | Day 1 through Day 28 | All randomized participants with any post-baseline data on Day 1 through Day 28. For those days when a participant is alive, but no data are available, last observation carried forward (LOFC) is used to impute the missing data. A non-surviving participant receives a score of 4 (worst score) for the day of death and every day thereafter. | units on a scale | MEAN |
| SECONDARY | Average Renal Sequential Organ Failure Assessment (SOFA) Score Day 1 Through Day 28 | Day 1 through Day 28 | All randomized participants with any post-baseline data on Day 1 through Day 28. For those days when a participant is alive, but no data are available, last observation carried forward (LOFC) is used to impute the missing data. A non-surviving participant receives a score of 4 (worst score) for the day of death and every day thereafter. | units on a scale | MEAN |
| SECONDARY | 90-Day Mortality | Day 90 | All randomized participants with known mortality status at Day 90. | percentage of participants | NUMBER |
| SECONDARY | 180-Day Mortality | Day 180 | All randomized participants with known mortality status at Day 180. | percentage of participants | NUMBER |
| SECONDARY | Median Survival Time | Day 180 | All randomized participants excluding those with unknown mortality status at Day 180. | days | MEDIAN |
| SECONDARY | EuroQoL Questionnaire-5 Dimensions (EQ-5D) Visual Analog Scale (VAS) Scores at Baseline, Days 28, 90 and 180 | Baseline and Days 28 and 90 and 180 | All randomized participants with EQ-5D VAS data at the specified time points. | units on a scale | MEAN |
| SECONDARY | EuroQoL Questionnaire-5 Dimensions (EQ-5D) Total Scores at Baseline, Days 28, 90 and 180 | Baseline and Days 28 and 90 and 180 | All randomized participants with EQ-5D total score data at the specified time points. | units on a scale | MEAN |
| SECONDARY | Quality of Life Short Form-12 (SF-12) Scores at Baseline, Days 28, 90 and 180 | Baseline and Days 28 and 90 and 180 | All randomized participants with SF-12 score data at the specified time points. | units on a scale | MEDIAN |
| OTHER_PRE_SPECIFIED | Percentage of Participants With Serious Bleeding Events Within System Organ Class Any Time From Baseline Through Day 28 | Baseline through Day 28 | Participants who received study drug. | percentage of participants | NUMBER |
| SECONDARY | Percentage of Participants Discontinued Due to Adverse Events Any Time From Baseline Through Day 28 Endpoint | Baseline through Day 28 | Participants who received study drug. | percentage of participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00604214/outcomes